Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4217848 | Academic Radiology | 2014 | 12 Pages |
Abstract
A limited number of studies suggest that the value of MRI to target prostate cancer in patients with previous negative biopsies and elevated PSA levels appears significant. MRI combined with MRSI is particularly accurate. Further studies are necessary to confirm the eventual role of DWI in this field.
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
Zai-Xian MD, PhD, Jia MD, PhD, Cheng-Zhong MD, Kang-An MD, PhD, Qi-Meng MD, PhD, Xi-Fu MD, PhD, Han MD, PhD, Gui-Xiang MD, PhD,